Zolinza capsules 100mg, manufactured by MSD, contains Vorinostat, a histone deacetylase (HDAC) inhibitor used for treating cutaneous T-cell lymphoma (CTCL) that has progressed or recurred after prior therapies. This 100mg 1 capsule formulation has a YJ code of 4291025M1029.
Zolinza capsules 100mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →